These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 11874410

  • 1. Effects of low-dose oral hydrocortisone replacement versus short-term reproduction of physiological serum cortisol concentrations on insulin action in adult-onset hypopituitarism.
    McConnell EM, Bell PM, Ennis C, Hadden DR, McCance DR, Sheridan B, Atkinson AB.
    Clin Endocrinol (Oxf); 2002 Feb; 56(2):195-201. PubMed ID: 11874410
    [Abstract] [Full Text] [Related]

  • 2. The effects on insulin action in adult hypopituitarism of recombinant human GH therapy individually titrated for six months.
    McConnell EM, Atkinson AB, Ennis C, Hadden DR, McCance DR, Sheridan B, Bell PM.
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5342-7. PubMed ID: 11701703
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of diabetes and impaired glucose tolerance in adult hypopituitarism on low dose oral hydrocortisone replacement therapy.
    McConnell EM, Bell PM, Hadden DR, McCance DR, Sheridan B, Atkinson AB.
    Clin Endocrinol (Oxf); 2001 May; 54(5):593-9. PubMed ID: 11380489
    [Abstract] [Full Text] [Related]

  • 4. Hydrocortisone replacement therapy in children and adolescents with hypopituitarism.
    DeVile CJ, Stanhope R.
    Clin Endocrinol (Oxf); 1997 Jul; 47(1):37-41. PubMed ID: 9302370
    [Abstract] [Full Text] [Related]

  • 5. Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults.
    al-Shoumer KA, Beshyah SA, Niththyananthan R, Johnston DG.
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):85-90. PubMed ID: 7889636
    [Abstract] [Full Text] [Related]

  • 6. Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.
    Björnsdottir S, Øksnes M, Isaksson M, Methlie P, Nilsen RM, Hustad S, Kämpe O, Hulting AL, Husebye ES, Løvås K, Nyström T, Bensing S.
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):28-35. PubMed ID: 25400085
    [Abstract] [Full Text] [Related]

  • 7. Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.
    Agha A, Liew A, Finucane F, Baker L, O'Kelly P, Tormey W, Thompson CJ.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):688-93. PubMed ID: 15163331
    [Abstract] [Full Text] [Related]

  • 8. Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism.
    Al-Shoumer KA, Ali K, Anyaoku V, Niththyananthan R, Johnston DG.
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):171-8. PubMed ID: 8881449
    [Abstract] [Full Text] [Related]

  • 9. Effects of dehydroepiandrosterone sulphate (DHEAS) replacement on insulin action and quality of life in hypopituitary females: a double-blind, placebo-controlled study.
    McHenry CM, Bell PM, Hunter SJ, Thompson CJ, Courtney CH, Ennis CN, Sheridan B, McCance DR, Mullan KR, Atkinson AB.
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):423-9. PubMed ID: 22420492
    [Abstract] [Full Text] [Related]

  • 10. Prolonged hypocortisolemia in hydrocortisone replacement regimens in adrenocorticotrophic hormone deficiency.
    Maguire AM, Ambler GR, Moore B, McLean M, Falleti MG, Cowell CT.
    Pediatrics; 2007 Jul; 120(1):e164-71. PubMed ID: 17576782
    [Abstract] [Full Text] [Related]

  • 11. Hydrocortisone replacement dosage influences intraocular pressure in patients with primary and secondary hypocortisolism.
    Li Voon Chong JS, Sen J, Johnson Z, Kyle G, MacFarlane IA.
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):267-71. PubMed ID: 11207643
    [Abstract] [Full Text] [Related]

  • 12. Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects.
    Nielsen MF, Caumo A, Chandramouli V, Schumann WC, Cobelli C, Landau BR, Vilstrup H, Rizza RA, Schmitz O.
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E102-10. PubMed ID: 12965873
    [Abstract] [Full Text] [Related]

  • 13. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism.
    Isidori AM, Kaltsas GA, Perry L, Burrin JM, Besser GM, Monson JP.
    Clin Endocrinol (Oxf); 2003 May; 58(5):601-11. PubMed ID: 12699442
    [Abstract] [Full Text] [Related]

  • 14. Glucocorticoid replacement therapy and fibrinolysis in patients with hypopituitarism.
    Peacey SR, Wright D, Aye M, Moisey R.
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):94-8. PubMed ID: 22151005
    [Abstract] [Full Text] [Related]

  • 15. Low-dose hydrocortisone replacement is associated with improved arterial stiffness index and blood pressure dynamics in severely adrenocorticotrophin-deficient hypopituitary male patients.
    Behan LA, Carmody D, Rogers B, Hannon MJ, Davenport C, Tormey W, Smith D, Thompson CJ, Stanton A, Agha A.
    Eur J Endocrinol; 2016 Jun; 174(6):791-9. PubMed ID: 27025241
    [Abstract] [Full Text] [Related]

  • 16. Acute effect of increasing glucocorticoid replacement dose on cardiovascular risk and insulin sensitivity in patients with adrenocorticotrophin deficiency.
    Petersons CJ, Mangelsdorf BL, Thompson CH, Burt MG.
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2269-76. PubMed ID: 24606100
    [Abstract] [Full Text] [Related]

  • 17. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
    Laursen T, Jørgensen JO, Jakobsen G, Hansen BL, Christiansen JS.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone, cortisol, or both are involved in defense against, but are not critical to recovery from, hypoglycemia.
    Boyle PJ, Cryer PE.
    Am J Physiol; 1991 Mar; 260(3 Pt 1):E395-402. PubMed ID: 2003593
    [Abstract] [Full Text] [Related]

  • 19. Low-dose hydrocortisone replacement therapy is associated with improved bone remodelling balance in hypopituitary male patients.
    Behan LA, Kelleher G, Hannon MJ, Brady JJ, Rogers B, Tormey W, Smith D, Thompson CJ, McKenna MJ, Agha A.
    Eur J Endocrinol; 2014 Jan; 170(1):141-50. PubMed ID: 24123094
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism.
    Dunne FP, Elliot P, Gammage MD, Stallard T, Ryan T, Sheppard MC, Stewart PM.
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):623-9. PubMed ID: 8548948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.